LaCAR, a Belgian genetic diagnostics company, has strategically acquired Baebies' newborn screening department to expand its presence in the U.S. market and enhance its product portfolio.

Information on the Target

Arnaud Allaer is the CEO and founder of LaCAR, a genetic diagnostics company based in Liège, Belgium. Coming from a background steeped in entrepreneurship, particularly in the biotech sector—thanks to his father, Didier Allaer, founder of Diagenode—Arnaud is dedicated to creating impactful solutions that make a difference in people's lives. Upon graduating with a degree in commercial engineering from ULiège, he embarked on his entrepreneurial journey, seeking innovative projects, particularly those with a significant societal impact.

LaCAR began its journey with an initial investment of €50,000, targeting the adaptation of DNA-free analysis kits initially developed for plants and animals to human genetic diagnostics. Collaboration with esteemed professionals, including experts from CHU de Liège, helped to validate Arnaud's vision. Despite facing initial challenges where the company's plan did not proceed as anticipated, LaCAR eventually secured funding to establish a small laboratory and successfully developed its first two products.

Industry Overview in Belgium

Belgium's biotechnology sector is recognized for its innovation and rapid growth, with a focus on medical diagnostics and the development of novel therapeutic solutions. The country boasts numerous research institutions and uni

View Source

Similar Deals

Dienstenthuis Domocura

2025

Other Healthcare Facilities & Services (NEC) Belgium
Cochlear, Resmed, Nyxoah’s Chairman and Management Nyxoah SA

2025

Other Medical Devices & Implants Belgium
Smile Invest MedEnvision

2024

Other Medical Devices & Implants Belgium
Sanofi, Invus Agomab Therapeutics NV

2024

Other Bio Therapeutic Drugs Belgium
Meducation@Work VITA BV

2023

Other Ambulance & Emergency Services Belgium
Fidelity Management & Research Company Agomab Therapeutics NV

2023

Other Proprietary & Advanced Pharmaceuticals Belgium

LaCAR

invested in

ZenTech

in 2022

in a Other deal

Disclosed details

Revenue: $12M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert